Meals being air freighted, plus armies of delivery robots.
As part of its multi billion-dollar plan to build a nationwide network of automated logistics, China’s JD.com is testing its tri-copter drones in testing zone in Shaanxi.
Chinese companies are going all-out on unmanned systems for delivery logistics. A fleet of new autonomous cargo drones, robotic trucks, and fast quadcopters are private-sector developments that are making China a future world leader in robotics.
Another at-home fitness company is making its debut today. Mirror is coming out of stealth mode with the introduction of its eponymous device. It’s a mirror atop a 40-inch, 1080p vertical display that plays live or prerecorded fitness classes. The idea is that you can stand in front of the mirror, follow a trainer’s instructions that are displayed behind your reflection, and still see yourself working out. It’s in stark contrast to people having to prop their phones up to watch a class or working out in their living rooms because it’s where their TV is. The device costs $1,495. Yes, that’s right. It’s very expensive. With it, you get a heart rate monitor that straps across your chest and resistance bands. A monthly content subscription costs $39.
The device includes built-in speakers, so there’s no need to hook up external audio, although you can over Bluetooth. You can play your own music through Spotify Premium or rely on Mirror’s own music. The class will automatically load a playlist, but users can swap those out as they want. It also features a 5-megapixel built-in camera at the top with a privacy cover. This is only used if users pay for personal training sessions.
From wealth management to autonomous robots: four prominent startups at the end of 2018
Investors are no longer interested in ICO projects with no real use. According to Icodata, $150 million were raised in October 2018 through token sales compared to $1.5 billion in January of the same year. “The blockchain space is getting to the point where there’s a ceiling in sight,” claims Ethereum co-founder Vitalik Buterin. The Russian-Canadian programmer believes that the next step will be “real applications of real economic activity.”
Despite the statements and hopes that the end of 2018 will bring about a return to practicality, it is still difficult for applicable projects to break through the information noise. We have picked out four noteworthy blockchain projects that have not yet gained traction in the media, despite featuring a range of out-of-the-box solutions.
Fast and fierce: The Embraer E190-E2, nicknamed the Profit Hunter, is part of the E2 family of regional jets, which encompasses the E175-E2, E190-E2, and E195-E.
(CNN) — There’s a shark on the runway.
No, it’s not some nightmare scenario brought about by severe flooding, but a real-deal Embraer E190-E2 aircraft, painted up in a special great white shark livery.
In recent months, this ferocious flier has been turning heads and starring in travel Instagrams from the Maldives to South Africa while on a world tour and in October, it was spied at Nepal’s Kathmandu-Tribhuvan International Airport following a fly-past of Mount Everest.
Nicknamed the Profit Hunter, this is the show plane for Embraer’s E2 family of regional jets, which encompasses the E175-E2, E190-E2, and E195-E2, and it’s stealing some of the attention that’s lately been lavished on its competitor, the Airbus A220.
Three companies want to test out a pilot project in Northern England by 2028.
Three natural gas distributors issued a report this week detailing plans to convert the UK’s residential gas system to a hydrogen delivery system. UK firms Northern Gas Networks and Cadent, as well as Norwegian gas firm Equinor, wrote that the proposal (PDF) was technically feasible. They also suggested an initial roll-out of the program to 3.7 million homes and 400,000 businesses in Northern England could commence as soon as 2028.
Everyone is on drugs. I don’t mean the old-fashioned, illegal kind, but the kind made by pharmaceutical companies that come in the form of pills. As a psychoanalyst, I’ve listened to people through the screen of their daily doses; and I’ve listened to them without it. Their natural rhythms certainly change, sometimes very dramatically—I guess that’s the point, isn’t it? I have a great many questions about what happens when a mind—a mind that uniquely structures emotion, interest, excitement, defense, association, memory, and rest—is undercut by medication. In this Faustian bargain, what are we gaining? And what are we sacrificing?
There is new resistance to the easy solution of medicating away psychological problems, because of revelations about addiction and abuse, a better understanding of placebo effects, or, for example, the startling realization that antidepressants, far from saving some teenagers from committing suicide, can sometimes push them to do it, which means that these pills should not be a first line of defense. Perhaps the time is right to return to the conundrum of mind and medicine.
The story of psychopharmacology stretches from the advent of barbiturates at the turn of the century to the discovery in the early 1950s of the first antipsychotic, based on a powerful sedative used for surgical purposes that was described as a “non-permanent pharmacological lobotomy.” This drug, Chlorpromazine, led to the development of most of the drugs used today for psychiatric management. The proliferation of psychiatric medications, ones with supposedly less overt dangers, began in the late 1980s—at the same time, a watershed lawsuit was filed in the UK against the makers of benzodiazepines, a class of drugs used for treating anxiety and other disorders, for knowingly downplaying knowledge of their potential for causing harm. Today, psychopharmacology is a multibillion-dollar industry and an estimated one in six adults in America is on some form of psychiatric medication (a statistic that doesn’t even include the use of sleeping pills, or pain pills, or the off-label use of other medications for psychological purposes).
A daring effort is under way to create the first children whose DNA has been tailored using gene editing.
When Chinese researchers first edited the genes of a human embryo in a lab dish in 2015, it sparked global outcry and pleas from scientists not to make a baby using the technology, at least for the present.
It was the invention of a powerful gene-editing tool, CRISPR, which is cheap and easy to deploy, that made the birth of humans genetically modified in an in vitro fertilization (IVF) center a theoretical possibility.
Thanks to genetically engineered pigs, the donor-organ shortage could soon be a think of the past.
ANCHORING A ROW of family photos in Joseph Tector’s office is a framed, autographed picture of Baby Fae, the California newborn who made headlines in 1984 when she received a baboon’s heart to replace her own malfunctioning organ.
It’s inscribed “To Joe” by Leonard L. Bailey, the surgeon who turned to the monkey heart as the only option to keep his patient alive. Bailey snapped the picture about five days after the operation, while Stephanie Fae Beauclair was sleeping. A strip of surgical tape runs down the center of her chest from neck to diaper, marking the incision line where her rib cage was pulled apart to make the swap. Baby Fae would die less than three weeks later.
It’s an unsettling image to come upon while glancing over snapshots of someone’s dutifully smiling children. But to Tector, who was 19 at the time of Baby Fae’s surgery, the cross-species organ transplant was the most inspiring thing he’d ever heard of. “I remember where I was when the news broke,” he says. “At that moment I knew exactly what I wanted to do with my life.” What he wanted to do with his life, though he may not have articulated it precisely this way, was to become a surgeon-scientist trying to crack the problem of xenotransplantation — the placing of animal organs into human bodies.
This Map Shows the Largest Employer in Every State.
Take a look at this map. What’s the first thing that catches your eye?
If your reaction was “Wow, Walmart controls A LOT of the country,” you’d be right. This map shows the largest private employer in every state in the U.S., and Walmart is tops in an incredible 22 states. In total, the company employs 1.5 million Americans.
Here’s a full state-by-state list for you to peruse. Who’s #1 in your state?
The FCC this week unanimously approved SpaceX’s ambitious plan to launch 7,518 satellites into low-Earth orbit. These satellites, along with 4,425 previously approved satellites, will serve as the backbone for the company’s proposed Starlink broadband network. As it does with most of its projects, SpaceX is thinking big with its global broadband network. The company is expected to spend more than $10 billion to build and launch a constellation of satellites that will provide high-speed internet coverage to just about every corner of the planet.
SpaceX plans initially to launch 4,425 Starlink satellites into a low-Earth orbit followed by an additional 7,518 satellite at an even lower orbit. The first group of satellites will operate at an altitude of 1,110km to 1,325km and will form the backbone of the company’s Starlink broadband service. The additional satellites will circle the Earth at altitudes from 335km to 346km and will boost capacity and lower latency, especially in densely populated areas. Because of these low orbits, SpaceX says its planned Starlink broadband network will have latencies as low as 25ms and gigabit speeds that will rival existing cable or fiber optic systems. Not only will it be fast, but the Starlink network also will reach those areas that have poor or no internet connectivity.
A new easy-to-use device can quickly and accurately screen for a variety of diseases, including Zika, Ebola, hepatitis, dengue, and malaria.
The portable device, called enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids), can also screen for various types of cancers and genetic diseases. EnVision takes between 30 minutes to one hour to detect the presence of diseases, which is two to four times faster than existing infection diagnostics methods. The device also costs less than 75¢—100 times less than tests currently in use.
“The enVision platform is extremely sensitive, accurate, fast, and low-cost. It works at room temperature and does not require heaters or special pumps, making it very portable,” says team leader Shao Huilin, assistant professor from the Biomedical Institute for Global Health Research and Technology (BIGHEART) and biomedical engineering department at National University of Singapore.
PERTH-based Fastbrick Robotics has achieved what it says is a world-first with the fully automated construction of a three-bedroom, two-bathroom house in less than three days.
The ASX-listed company says civil and structural engineers verified that the structure — completed on Monday in WA by a robotic arm from a 3D model — met relevant building standards, setting the stage for commercialisation of the product.
The company’s share price soared on the news after coming out of a trading halt, jumping more than 21 per cent, or 3.5¢, to 20¢ by 12.30pm.
